Biologics Fill Finish Manufacturing Market 규모 및 점유율 분석 - 성장 추세 및 예측 (2024 - 2031)

Biologics Fill Finish Manufacturing Market is Segmented By Product Type (Vials, Prefilled Syringes, Cartridges, Ampoules, Others (Bags, Bottles, etc.)), By Molecule Type (Monoclonal Antibodies, Vaccines, Proteins, Peptides, Others (Cells, Gene Therapies, etc.)), By Scale of Operation (Large-scale Manufacturing, Small-scale/Specialty Manufacturing), By End User (Pharmaceutical/Biopharmaceutical Companies, Research Laboratories, Academic Institutions, Others (Government Agencies, Clinics, etc.)), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.

Competitive overview of Biologics Fill Finish Manufacturing Market

Biologics Fill Finish Manufacturing Market에서 운영하는 주요 플레이어는 WuXi Biologics, Lonza, Catalent Biologics, Boehringer Ingelheim BioXcellence, AbbVie Contract Manufacturing, Charles River, Evonik, Sandoz, Patheon Pharma Services, Recipharm, Pierre Fabre, Fresenius Kabi, GSK, Asymchem, Hetero, Syngene 및 WACKER를 포함합니다.

Biologics Fill Finish Manufacturing Market Leaders

  • AbbVie 계약 제조
  • 보링거 Ingelheim BioXcellence
  • Catalent 생물 공학
  • 런자
  • WuXi 생물 공학
*Disclaimer: Major players are listed in no particular order.

Biologics Fill Finish Manufacturing Market - Competitive Rivalry, 2023

Market Concentration Graph

Biologics Fill Finish Manufacturing Market

Market Consolidated
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
*Source: Coherent Market Insights